- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/864 - Parvoviral vectors
Patent holdings for IPC class C12N 15/864
Total number of patents in this class: 1992
10-year publication summary
|
90
|
93
|
95
|
184
|
185
|
175
|
178
|
200
|
211
|
101
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4308 |
89 |
| University of Florida Research Foundation, Inc. | 3989 |
63 |
| Research Institute at Nationwide Children's Hospital | 555 |
43 |
| The University of North Carolina at Chapel Hill | 2025 |
32 |
| The Children's Hospital of Philadelphia | 782 |
30 |
| University of Massachusetts | 2218 |
30 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3360 |
29 |
| The Regents of the University of California | 19812 |
26 |
| Genethon | 251 |
24 |
| REGENXBIO Inc. | 248 |
24 |
| Voyager Therapeutics, Inc. | 256 |
22 |
| Centre National de La Recherche Scientifique | 10321 |
21 |
| The Board of Trustees of the Leland Stanford Junior University | 6365 |
21 |
| Genzyme Corporation | 1233 |
21 |
| President and Fellows of Harvard College | 5949 |
20 |
| Universitat Autonoma de Barcelona | 318 |
18 |
| University of Iowa Research Foundation | 813 |
17 |
| The Broad Institute, Inc. | 1785 |
16 |
| Sangamo Therapeutics, Inc. | 415 |
16 |
| Asklepios Biopharmaceutical, Inc. | 81 |
15 |
| Other owners | 1415 |